Skip to main content

Table 3 Detailed technical data and clinical outcomes of EUS-guided hepaticogastrostomy

From: Outcomes and limitations of endoscopic ultrasound-guided hepaticogastrostomy in malignant biliary obstruction

Factors All (n = 53)
Procedure time, min, mean, (SD), [range] 31.2 (15.0) [11–84]
Diameter of the punctured intrahepatic duct, mm, mean, (SD), [range] 12.79 (4.8) [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21]
Distance between the stomach and the punctured duct, mm, mean, (SD), [range] 22.74 (8.0) [10–33]
Side of puncture, n, (%)
 Liver segment II 7 (13.21%)
 Liver segment III 46 (86.79%)
Number of puncture, n, (%)
 1 32 (60.38%)
 2 13 (24.53%)
 3 3 (5.66%)
 4 5 (9.43%)
Technical success, n, (%) 52/53 (98.11%)
Complications of endoscopic treatment, n, (%) 10/53 (18.87%)
 Early complications 7 (13.21%)
 Late endoscopic treatment complications 3 (5.66%)
 The periprocedural mortality 4 (7.55%)
Clinical success of EUS-guided hepaticogastrostomy, n, (%) 46/53 (86.79%)